This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...
You are here because of a single, all-important enzyme. But don’t look inward to find ribulose-1,5-bisphosphate carboxylase/oxygenase, known more mercifully among scientists as rubisco. Instead, ...
Stanford Medicine's Consumer Health Summit brought together the intersection of data, diagnostics, wearables and consumer ...
Scientists at the University of Nevada, Reno have received a $9 million grant from the U.S. Department of Energy to find out whether cactus pear can become a viable biofuel crop.
Health bosses want to combine adult and children's A&E services for Southport and Ormskirk Hospitals.
So many options. So much noise. Here's what to know about GLP-1s now.
Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these ...
Christopher Buck is fermenting a vaccine in his kitchen. You can too. Specifically, Buck brews and quaffs a hazy beer that ...
Like many professors or teachers, I find myself confronting the role of artificial intelligence in the classroom. But I am not alone. Students are also concerned. They are worried about being ...
The CEO talked to the Warners' executive leaders but left some feeling unsatisfied. "We were hoping for more," says one insider. By Borys Kit Senior Film Writer Paramount CEO David Ellison made his ...
Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results